RPG Life Sciences Ltd approves unaudited Q2 and H1 FY27 results and revised Related Party Transactions Policy
- Results cover the quarter and half-year ended September 30, 2026.
- Statutory auditors’ limited review reports were also approved.
- The announcement does not include the results figures.
